About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Comparing Two Cardiac Pumps HeartMate II Versus HeartMate 3

by Chrisy Ngilneii on June 5, 2018 at 10:22 PM
Font : A-A+

Comparing Two Cardiac Pumps  HeartMate II Versus HeartMate 3

When it comes to cardiac pumps, newer products might offer new benefits older products do not.

A study compared cardiac pumps - the HeartMate II (current generation) and HeartMate 3 (a novel, centrifugal-flow pump) and finds that Heartmate 3 can minimize cost of care over time for heart failure patients.

Advertisement


HeartMate 3 reduces re-hospitalizations, number of days spent during re-hospitalizations, and is more cost saving following discharge when compared with the older cardiac pump HeartMate II.

"The HeartMate 3 left-ventricular assist device (LVAD) is a more forgiving pump in terms of clinical adverse events, and now we can confirm that its increased effectiveness is associated with decreased costs," said Mandeep Mehra, MD, executive director of the Center for Advanced Heart Disease and medical director of the Heart & Vascular Center at Brigham and Women's Hospital. "In medicine, most often, a therapy that demonstrates increased effectiveness usually comes at a higher price, and we are able to show that this new technology actually decreases costs to payers and patients over time."
Advertisement

Mehra and colleagues found that the newer device reduced costs due to re-hospitalization by 51 percent, largely driven by a decrease in stroke and pump malfunction requiring reoperation due to pump thrombosis. Patients who received the HeartMate 3 experienced fewer hospitalizations and, on average, spent 8.3 fewer days in the hospital per year than those who received the HeartMate II. The authors note that it may be possible to further reduce costs by decreasing outlier complications and reducing hospital length of stay, and decrease early complications by improving patient selection criteria and considering this therapy before patients get too sick.

In April, Abbott Inc. issued a field safety notice regarding HeartMate 3 outflow graft twist complications with an incidence rate of 0.72 percent. The FDA issued a Class I recall but did not recommend the return of LVADs or avoidance of use in new patients. The current study re-reviewed 20 hospitalizations (five in the HeartMate 3 and 15 in the HeartMate II populations) and in a conservative analysis, classified them as being device-related for the purposes of this analysis. Nonetheless, the data still demonstrated a reduction in re-hospitalization related hospital days and significant cost savings for the HeartMate 3 compared to the HeartMate II.

Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Heart Disease News

Why Is Timely Follow-Up After Heart Failure Hospitalization Important?
58% of adults with Type 2 diabetes covered by Alabama Medicaid did not receive prompt outpatient care after hospitalization for heart failure.
Monday: The Day for Deadly Heart Attacks?
The start of the week is when most fatal heart attacks occur, according to a study.
Delay in Seeking Care Results in 55% of Cardiac Deaths in India
The first community-based study, published in the journal Lancet, says that delays in seeking care account for nearly 55% of the reported cardiac and stroke deaths in India.
The Surprising Impact of Quit Smoking: 36% Lower Cardiovascular Risk
The study emphasizes the existing proof on the heart disease risks of tobacco smoking and the urgent need to stop smoking among cancer survivors.
 Discovering Genetic Risks for Type of Heart Attack Largely Affecting Younger Women
New study findings provide novel pathophysiological insights involving blood vessel integrity and tissue-mediated coagulation in a type of heart attack in young women.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Comparing Two Cardiac Pumps HeartMate II Versus HeartMate 3 Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests